Larazotide
most data4 sources
Larazotide is the rare peptide on this shelf with hundreds of patients in real trials. It tightens the gut lining, and in celiacs still symptomatic on a gluten-free diet, the 0.5 mg dose cut symptomatic days by 26%. The catch is that the phase 3 program failed, the higher doses did nothing, and almost all the evidence is celiac-specific. A small pediatric MIS-C trial is the one exception. If you have celiac disease and a strict gluten-free diet is not enough, larazotide is a genuine lead. If you are chasing general gut healing, the data barely extends past celiac.
What it is
Larazotide is a synthetic octapeptide that regulates the tight junctions between the cells lining your gut. When those junctions loosen, things that should stay inside the gut, like gliadin fragments from gluten, leak through and trigger immune flares. Larazotide tightens them back up. The mechanism is well established in cell and animal models: it rearranges the structural proteins, ZO-1, occludin, claudins, that form the seal between cells.
The clinical story is celiac disease, specifically people who maintain a strict gluten-free diet and still have symptoms, which is a larger group than you would think. Larazotide is not a general anti-inflammatory or a broad healing peptide. It does one thing, regulate the gut barrier, and the trial program tested it almost exclusively in one population. For broader healing work, BPC-157 and TB-500 cover more ground.
What the research shows
More human trial data than most peptides here, almost all celiac:
Realistic protocols
Oral, three times a day before meals, at the lowest dose. The trials made one thing clear: 0.5 mg works and higher does not. Larazotide has an inverted dose-response in the celiac data, where the higher doses showed no benefit at all, likely because the tight-junction regulation has a sweet spot and too much overshoots. So the protocol is simple and the dose is fixed.
Take it before meals because that is when gliadin exposure happens and when you want the gut barrier reinforced. It is an add-on to a gluten-free diet, not a replacement for one. The trials ran 12 weeks and showed consistent safety at that length.
Side effects
Clean safety across the celiac trials, hundreds of patients deep: